The interaction between HA and CD44 promotes antiapoptotic pathways induced by receptor tyrosine kinase (RTK) activation, enhances transporter activities, and confers cancer stem cells (CSCs) with resistance to oxidative stress. The gene discussed is CD44; the disease is cancer.